Literature DB >> 15795345

New Alström syndrome phenotypes based on the evaluation of 182 cases.

Jan D Marshall1, Roderick T Bronson, Gayle B Collin, Anne D Nordstrom, Pietro Maffei, Richard B Paisey, Catherine Carey, Seamus Macdermott, Isabelle Russell-Eggitt, Sarah E Shea, Judy Davis, Sebastian Beck, Gocha Shatirishvili, Cristina Maria Mihai, Maria Hoeltzenbein, Giovanni Battista Pozzan, Ian Hopkinson, Nicola Sicolo, Jürgen K Naggert, Patsy M Nishina.   

Abstract

BACKGROUND: Alström syndrome is a recessively inherited genetic disorder characterized by congenital retinal dystrophy that leads to blindness, hearing impairment, childhood obesity, insulin resistance, and type 2 diabetes mellitus. We provide new details on cardiologic, hepatic, gastrointestinal, urologic, pulmonary, and neurobehavioral phenotypes in Alström syndrome and describe the histopathologic findings in 5 individuals.
METHODS: We obtained data on 182 patients from clinical examinations, medical record reviews, standardized questionnaires, and personal interviews with physicians and parents.
RESULTS: Dilated cardiomyopathy occurred in 60% of patients. Age at onset was either during infancy, often before vision disturbances were noted, or in adolescence or adulthood. There is a risk of recurrence of infantile cardiomyopathy. Hyperinsulinemia (92%) developed in early childhood and progressed to type 2 diabetes mellitus in 82% of those older than 16 years. Hypertriglyceridemia (54%) precipitated pancreatitis in 8 patients. Urologic dysfunction and gastrointestinal disturbances occurred in 48% and 35% of patients, respectively. Fifty-three percent of patients had persistent pulmonary symptoms. Neurologic symptoms in 20% of patients included clonic tic and absence seizures. Developmental motor or language delays were observed in 46% of patients. Fibrotic infiltrations of multiple organs, that is, kidney, heart, liver, lung, urinary bladder, gonads, and pancreas, were observed.
CONCLUSIONS: The wide-ranging and complex spectrum of phenotypes reported herein broadens those previously described for Alström syndrome. These findings will aid physicians in making an early and accurate diagnosis and will help effect appropriate monitoring and treatment.

Entities:  

Mesh:

Year:  2005        PMID: 15795345     DOI: 10.1001/archinte.165.6.675

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  100 in total

1.  Alström Syndrome protein ALMS1 localizes to basal bodies of cochlear hair cells and regulates cilium-dependent planar cell polarity.

Authors:  Daniel Jagger; Gayle Collin; John Kelly; Emily Towers; Graham Nevill; Chantal Longo-Guess; Jennifer Benson; Karin Halsey; David Dolan; Jan Marshall; Jürgen Naggert; Andrew Forge
Journal:  Hum Mol Genet       Date:  2010-11-11       Impact factor: 6.150

Review 2.  Cilia and coordination of signaling networks during heart development.

Authors:  Karen Koefoed; Iben Rønn Veland; Lotte Bang Pedersen; Lars Allan Larsen; Søren Tvorup Christensen
Journal:  Organogenesis       Date:  2013-12-17       Impact factor: 2.500

3.  Characteristics of cardiomyopathy in Alström syndrome: Prospective single-center data on 38 patients.

Authors:  Alessandra Brofferio; Vandana Sachdev; Hwaida Hannoush; Jan D Marshall; Jürgen K Naggert; Stanislav Sidenko; Anna Noreuil; Arlene Sirajuddin; Joy Bryant; Joan C Han; Andrew E Arai; William A Gahl; Meral Gunay-Aygun
Journal:  Mol Genet Metab       Date:  2017-05-30       Impact factor: 4.797

4.  Alström Syndrome: Mutation Spectrum of ALMS1.

Authors:  Jan D Marshall; Jean Muller; Gayle B Collin; Gabriella Milan; Stephen F Kingsmore; Darrell Dinwiddie; Emily G Farrow; Neil A Miller; Francesca Favaretto; Pietro Maffei; Hélène Dollfus; Roberto Vettor; Jürgen K Naggert
Journal:  Hum Mutat       Date:  2015-05-18       Impact factor: 4.878

5.  Long-term clinical follow-up and molecular testing for diagnosis of the first Tunisian family with Alström syndrome.

Authors:  Amine Chakroun; Mariem Ben Said; Amine Ennouri; Imen Achour; Mouna Mnif; Mohamed Abid; Abdelmonem Ghorbel; Jan D Marshall; Jürgen K Naggert; Saber Masmoudi
Journal:  Eur J Med Genet       Date:  2016-08-12       Impact factor: 2.708

6.  Differential effects on β-cell mass by disruption of Bardet-Biedl syndrome or Alstrom syndrome genes.

Authors:  Sukanya Lodh; Timothy L Hostelley; Carmen C Leitch; Elizabeth A O'Hare; Norann A Zaghloul
Journal:  Hum Mol Genet       Date:  2015-10-22       Impact factor: 6.150

7.  Genomic insights into early-onset obesity.

Authors:  Hélène Choquet; David Meyre
Journal:  Genome Med       Date:  2010-06-23       Impact factor: 11.117

8.  Cardiac magnetic resonance imaging in Alström syndrome.

Authors:  Margaret A Loudon; Nicholas G Bellenger; Catherine M Carey; Richard B Paisey
Journal:  Orphanet J Rare Dis       Date:  2009-06-10       Impact factor: 4.123

Review 9.  Nephronophthisis.

Authors:  Rémi Salomon; Sophie Saunier; Patrick Niaudet
Journal:  Pediatr Nephrol       Date:  2008-07-08       Impact factor: 3.714

10.  Combined occurrence of diabetes mellitus and retinitis pigmentosa.

Authors:  Afaf Al-Adsani; Fadl Abdel Gader
Journal:  Ann Saudi Med       Date:  2010 Jan-Feb       Impact factor: 1.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.